Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: the NIH experience

Granulocyte transfusions are a relatively safe adjunctive therapeutic option for patients with chronic granulomatous disease and severe/refractory bacterial or fungal infections. Early initiation, high frequency and sustained therapy is associated with significantly better outcomes.

Saved in:
Bibliographic Details
Published in:J Allergy Clin Immunol
Main Authors: Marciano, Beatriz E., Allen, Elisabeth S., Cantilena, Cathy C., Kristosturyan, Ervand, Klein, Harvey G., Fleisher, Thomas A., Holland, Steven M., Malech, Harry L., Rosenzweig, Sergio D.
Format: Artigo
Language:Inglês
Published: 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5546986/
https://ncbi.nlm.nih.gov/pubmed/28342916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2017.02.026
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items